286 related articles for article (PubMed ID: 11352879)
1. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS).
Waksman R; Ajani AE; White RL; Pinnow E; Dieble R; Bui AB; Taaffe M; Gruberg L; Mintz GS; Satler LF; Pichard AD; Kent KK; Lindsay J
Circulation; 2001 May; 103(19):2332-5. PubMed ID: 11352879
[TBL] [Abstract][Full Text] [Related]
2. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS.
Waksman R; Ajani AE; Pinnow E; Cheneau E; Leborgne L; Dieble R; Bui AB; Satler LF; Pichard AD; Kent KK; Lindsay J
Circulation; 2002 Aug; 106(7):776-8. PubMed ID: 12176945
[TBL] [Abstract][Full Text] [Related]
3. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
[TBL] [Abstract][Full Text] [Related]
4. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting.
Leon MB; Teirstein PS; Moses JW; Tripuraneni P; Lansky AJ; Jani S; Wong SC; Fish D; Ellis S; Holmes DR; Kerieakes D; Kuntz RE
N Engl J Med; 2001 Jan; 344(4):250-6. PubMed ID: 11172151
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies.
Waksman R; Cheneau E; Ajani AE; White RL; Pinnow E; Torguson R; Deible R; Satler LF; Pichard AD; Kent KM; Teirstein PS; Lindsay J;
Circulation; 2003 Apr; 107(13):1744-9. PubMed ID: 12665490
[TBL] [Abstract][Full Text] [Related]
7. Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis.
Kuchulakanti P; Torguson R; Canos D; Satler LF; Suddath W; Chan R; White LR; Gevorkian N; Bui A; Wang B; Kent KM; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2005; 6(3):108-12. PubMed ID: 16275606
[TBL] [Abstract][Full Text] [Related]
8. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Tanabe Y; Ito E; Nakagawa I; Suzuki K
Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
[TBL] [Abstract][Full Text] [Related]
9. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with clopidogrel and aspirin after coronary stenting.
Kolansky DM; Klugherz BD; Curran SC; Herrmann HC; Magness K; Wilensky RL; Hirshfeld JW
Catheter Cardiovasc Interv; 2000 Jul; 50(3):276-9. PubMed ID: 10878621
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
[TBL] [Abstract][Full Text] [Related]
13. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis.
Waksman R; Bhargava B; Mintz GS; Mehran R; Lansky AJ; Satler LF; Pichard AD; Kent KM; Leon MB
J Am Coll Cardiol; 2000 Jul; 36(1):65-8. PubMed ID: 10898414
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study.
Byrne RA; Schulz S; Mehilli J; Iijima R; Massberg S; Neumann FJ; ten Berg JM; Schömig A; Kastrati A;
Am Heart J; 2009 Apr; 157(4):620-4.e2. PubMed ID: 19332187
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary radiation therapy using a novel beta emitter for in-stent restenosis Tungsten WRIST.
Dilcher C; Satler LF; Pichard AD; Kent KM; Porrazzo M; Chan R; Torguson R; Canos DA; Waksman R
Cardiovasc Revasc Med; 2005; 6(2):52-7. PubMed ID: 16263359
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting.
Dangas G; Mehran R; Abizaid AS; Curry BH; Lansky AJ; Kent KM; Pichard AD; Satler LF; Paliou M; Stone GW; Leon MB
Am J Cardiol; 2001 Feb; 87(4):470-2, A7. PubMed ID: 11179539
[TBL] [Abstract][Full Text] [Related]
17. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ
J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
19. A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
Chen YD; Lu YL; Jin ZN; Yuan F; Lü SZ
Chin Med J (Engl); 2006 Mar; 119(5):360-6. PubMed ID: 16542577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
